Ameliorating Cardiovascular Risk in Patients with Type 2 Diabetes

Abstract

Patients with type 2 diabetes (T2D) are at an increased risk of cardiovascular disease (CVD), which constitutes the most common cause of morbidity and mortality in these patients. Intensive CVD risk factor control can ameliorate the elevated CVD associated with T2D. In this review, we provide an overview of CVD risk factor control, including traditional (blood pressure, glycemia, lipid, thrombosis, and lifestyle modifications) and nontraditional (social and environmental determinants of health) in patients with T2D, including evidence on management and outcomes.

PubMed ID

36754490

Cite

Motairek I, Al-Kindi S. Ameliorating Cardiovascular Risk in Patients with Type 2 Diabetes. Endocrinol Metab Clin North Am. 2023 Mar;52(1):135-147. doi: 10.1016/j.ecl.2022.07.002. Epub 2022 Nov 18. PMID: 36754490.

Center(s)

Publish Date

11/18/2022